Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR Medicine, Hematology and Medical Oncology ASSISTANT PROFESSOR Urology
Fingerprint
Dive into the research topics where Deepu Madduri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma
Raghunandan, S., Pauly, M., Blum, W. G., Qayed, M., Dhodapkar, M. V., Elkhalifa, M., Watkins, B., Schoettler, M., Horwitz, E., Parikh, S., Chandrakasan, S., Leung, K., Bryson, E., Deeb, L., Kaufman, J. L., Worthington-White, D., Alazraki, A., Schecter, J. M., Madduri, D., Jackson, C. C., & 8 others, 3 May 2023, In: Journal for ImmunoTherapy of Cancer. 11, 5, e006684.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study
Cohen, A. D., Hari, P., Htut, M., Berdeja, J. G., Usmani, S. Z., Madduri, D., Olyslager, Y., Goldberg, J. D., Schecter, J. M., Jackson, C. C., Gries, K. S., Fastenau, J. M., Valluri, S., Deraedt, W., Akram, M., Crawford, R., Morrison, R., Doward, L., Morgan, K., Seldam, S. T., & 2 others, Jan 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 1, p. 68-77 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Plain language summary of the CARTITUDE-1 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma
Berdeja, J. G., Cohen, A. D., Martin, T., Madduri, D., Pacaud, L. & Jagannath, S., 1 Jun 2023, In: Future Oncology. 19, 18, p. 1235-1247 13 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Recent Advances in the Use of Chimeric Antigen Receptor–Expressing T-Cell Therapies for Treatment of Multiple Myeloma: Clinically advanced CAR-T therapies for RRMM
Martin, T., Jackson, C. C., Pacaud, L., Madduri, D. & Jagannath, S., Jan 2023, In: Clinical Lymphoma, Myeloma and Leukemia. 23, 1, p. 22-27 6 p.Research output: Contribution to journal › Short survey › peer-review
1 Scopus citations -
Anti-Granulocyte–Macrophage Colony–Stimulating Factor Monoclonal Antibody Gimsilumab for COVID-19 Pneumonia A Randomized, Double-Blind, Placebo-controlled Trial
Criner, G. J., Lang, F. M., Gottlieb, R. L., Mathews, K. S., Wang, T. S., Rice, T. W., Madduri, D., Bellam, S., Jeanfreau, R., Case, A. H., Glassberg, M. K., Lyon, G. M., Ahmad, K., Mendelson, R., DiMaio, J. M., Tran, M. A. P., Spak, C. W., Abbasi, J. A., Davis, S. G., Ghamande, S., & 3 others, 1 Jun 2022, In: American Journal of Respiratory and Critical Care Medicine. 205, 11, p. 1290-1299 10 p.Research output: Contribution to journal › Article › peer-review
Open Access15 Scopus citations
Press/Media
-
Mount Sinai Health System: Potentially Serious Side Effect Seen in Patient after Immunotherapy
Samir Parekh, Miriam Merad, Seunghee Kim-Schulze, Joshua Brody, Adeeb Rahman, Sundar Jagannath, Alessandro Laganà, Charles Stacy, Julie Teruya-Feldstein & Deepu Madduri
10/12/21 → 11/12/21
8 items of Media coverage
Press/Media
-
Scientists identify new types of a blood cancer and potential targeted treatments
David Melnekoff, Joshua Richter, Samir Parekh, Violetta V. Leshchenko, Ajai Chari, Sundar Jagannath, Alessandro Laganà, Joel Dudley, Kenen Onel, Deepu Madduri & Hearn Cho
17/11/21
1 item of Media coverage
Press/Media
-
Many Factors Influence Which Cell-Based Treatment Options are Best for Patients with Multiple Myeloma, Expert SaysArticle
30/03/21
1 item of Media coverage
Press/Media
-
CAR T-CELL THERAPY GENERATES LASTING REMISSIONS IN PATIENTS WITH MULTIPLE MYELOMA
24/02/21 → 25/02/21
3 items of Media coverage
Press/Media